ADMET and DMPK, Vol. 4 No. 3, 2016.
Editorial
https://doi.org/10.5599/admet.4.2.348
ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors
Godefridus Peters
orcid.org/0000-0002-5447-2877
; Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands.
Kin Tam
; Faculty of Health Sciences, University of Macau, Taipa, Macau
Abstract
Editorial
Keywords
ADME; DMPK; tyrosine kinase, serine-threonine kinase
Hrčak ID:
167041
URI
Publication date:
30.9.2016.
Visits: 1.283 *